论文信息 - Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists - 字舞流文

Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists

[1] Ö. Acar,et al. Prostate‐specific membrane antigen‐based imaging in prostate cancer: Impact on clinical decision making process , 2015, The Prostate.

[2] M. Schwaiger,et al. Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy , 2015, The Journal of Nuclear Medicine.

[3] P. Hoskin,et al. Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease. , 2015, The British journal of radiology.

[4] T. Holland-Letz,et al. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[5] S. Groshen,et al. Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature. , 2014, American journal of nuclear medicine and molecular imaging.

[6] Shankar Vallabhajosula,et al. Prostate-specific membrane antigen-based imaging. , 2013, Urologic oncology.

[7] D. Bostwick,et al. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. , 1998, Urology.